The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Hyaluronic Acid for Osteoarthritis-Global Market Insights and Sales Trends 2025

Hyaluronic Acid for Osteoarthritis-Global Market Insights and Sales Trends 2025

Publishing Date : Mar, 2025

License Type :
 

Report Code : 1808558

No of Pages : 109

Ask Your Query
Synopsis
Hyaluronan is a natural substance found in the body and is present in very high amounts in joints. The body’s own hyaluronan acts like a lubricant and a shock absorber in the joint and is needed for the joint to work properly. Hyaluronic acid is similar to a substance that occurs naturally in the joints. It works by acting like a lubricant and shock absorber in the joints and helps the joints to work properly.
The global Hyaluronic Acid for Osteoarthritis market size is expected to reach US$ 806.5 million by 2029, growing at a CAGR of 6.3% from 2023 to 2029. The market is mainly driven by the significant applications of Hyaluronic Acid for Osteoarthritis in various end use industries. The expanding demands from the Knee Joint, Hip Joint, Shoulder Joint and Ankle Joint, are propelling Hyaluronic Acid for Osteoarthritis market. Single-Phase, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Duplex segment is estimated at % CAGR for the next seven-year period.
Asia Pacific shows high growth potential for Hyaluronic Acid for Osteoarthritis market, driven by demand from China, the second largest economy with some signs of stabilising, the Hyaluronic Acid for Osteoarthritis market in China is forecast to reach US$ million by 2029, trailing a CAGR of % over the 2023-2029 period, while the U.S. market will reach US$ million by 2029, exhibiting a CAGR of % during the same period.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Hyaluronic Acid for Osteoarthritis, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Hyaluronic Acid for Osteoarthritis market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Hyaluronic Acid for Osteoarthritis market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Hyaluronic Acid for Osteoarthritis sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Hyaluronic Acid for Osteoarthritis covered in this report include BIOVENTUS, Sanofi, Ferring B.V., Anika Therapeutics, Fidia Farma, LG Chem, Bohus BioTech, Hangzhou Singclean Medical Products and Biolevox, etc.
The global Hyaluronic Acid for Osteoarthritis market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
BIOVENTUS
Sanofi
Ferring B.V.
Anika Therapeutics
Fidia Farma
LG Chem
Bohus BioTech
Hangzhou Singclean Medical Products
Biolevox
Vivacy
ideolab
Xediton Pharmaceuticals
Deka
BIOIBERICA
Global Hyaluronic Acid for Osteoarthritis market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Hyaluronic Acid for Osteoarthritis market, Segment by Type:
Single-Phase
Duplex
Global Hyaluronic Acid for Osteoarthritis market, by Application
Knee Joint
Hip Joint
Shoulder Joint
Ankle Joint
Others
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Hyaluronic Acid for Osteoarthritis manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Hyaluronic Acid for Osteoarthritis in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Index
1 Hyaluronic Acid for Osteoarthritis Market Overview
1.1 Hyaluronic Acid for Osteoarthritis Product Overview
1.2 Hyaluronic Acid for Osteoarthritis Market Segment by Type
1.2.1 Single-Phase
1.2.2 Duplex
1.3 Global Hyaluronic Acid for Osteoarthritis Market Size by Type
1.3.1 Global Hyaluronic Acid for Osteoarthritis Market Size Overview by Type (2018-2029)
1.3.2 Global Hyaluronic Acid for Osteoarthritis Historic Market Size Review by Type (2018-2023)
1.3.3 Global Hyaluronic Acid for Osteoarthritis Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Hyaluronic Acid for Osteoarthritis Sales Breakdown by Type (2018-2023)
1.4.2 Europe Hyaluronic Acid for Osteoarthritis Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Hyaluronic Acid for Osteoarthritis Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Hyaluronic Acid for Osteoarthritis Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Hyaluronic Acid for Osteoarthritis Sales Breakdown by Type (2018-2023)
2 Global Hyaluronic Acid for Osteoarthritis Market Competition by Company
2.1 Global Top Players by Hyaluronic Acid for Osteoarthritis Sales (2018-2023)
2.2 Global Top Players by Hyaluronic Acid for Osteoarthritis Revenue (2018-2023)
2.3 Global Top Players by Hyaluronic Acid for Osteoarthritis Price (2018-2023)
2.4 Global Top Manufacturers Hyaluronic Acid for Osteoarthritis Manufacturing Base Distribution, Sales Area, Product Type
2.5 Hyaluronic Acid for Osteoarthritis Market Competitive Situation and Trends
2.5.1 Hyaluronic Acid for Osteoarthritis Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Hyaluronic Acid for Osteoarthritis Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Hyaluronic Acid for Osteoarthritis as of 2022)
2.7 Date of Key Manufacturers Enter into Hyaluronic Acid for Osteoarthritis Market
2.8 Key Manufacturers Hyaluronic Acid for Osteoarthritis Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Hyaluronic Acid for Osteoarthritis Status and Outlook by Region
3.1 Global Hyaluronic Acid for Osteoarthritis Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Hyaluronic Acid for Osteoarthritis Historic Market Size by Region
3.2.1 Global Hyaluronic Acid for Osteoarthritis Sales in Volume by Region (2018-2023)
3.2.2 Global Hyaluronic Acid for Osteoarthritis Sales in Value by Region (2018-2023)
3.2.3 Global Hyaluronic Acid for Osteoarthritis Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Hyaluronic Acid for Osteoarthritis Forecasted Market Size by Region
3.3.1 Global Hyaluronic Acid for Osteoarthritis Sales in Volume by Region (2024-2029)
3.3.2 Global Hyaluronic Acid for Osteoarthritis Sales in Value by Region (2024-2029)
3.3.3 Global Hyaluronic Acid for Osteoarthritis Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Hyaluronic Acid for Osteoarthritis by Application
4.1 Hyaluronic Acid for Osteoarthritis Market Segment by Application
4.1.1 Knee Joint
4.1.2 Hip Joint
4.1.3 Shoulder Joint
4.1.4 Ankle Joint
4.1.5 Others
4.2 Global Hyaluronic Acid for Osteoarthritis Market Size by Application
4.2.1 Global Hyaluronic Acid for Osteoarthritis Market Size Overview by Application (2018-2029)
4.2.2 Global Hyaluronic Acid for Osteoarthritis Historic Market Size Review by Application (2018-2023)
4.2.3 Global Hyaluronic Acid for Osteoarthritis Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Hyaluronic Acid for Osteoarthritis Sales Breakdown by Application (2018-2023)
4.3.2 Europe Hyaluronic Acid for Osteoarthritis Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Hyaluronic Acid for Osteoarthritis Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Hyaluronic Acid for Osteoarthritis Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Hyaluronic Acid for Osteoarthritis Sales Breakdown by Application (2018-2023)
5 North America Hyaluronic Acid for Osteoarthritis by Country
5.1 North America Hyaluronic Acid for Osteoarthritis Historic Market Size by Country
5.1.1 North America Hyaluronic Acid for Osteoarthritis Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Hyaluronic Acid for Osteoarthritis Sales in Volume by Country (2018-2023)
5.1.3 North America Hyaluronic Acid for Osteoarthritis Sales in Value by Country (2018-2023)
5.2 North America Hyaluronic Acid for Osteoarthritis Forecasted Market Size by Country
5.2.1 North America Hyaluronic Acid for Osteoarthritis Sales in Volume by Country (2024-2029)
5.2.2 North America Hyaluronic Acid for Osteoarthritis Sales in Value by Country (2024-2029)
6 Europe Hyaluronic Acid for Osteoarthritis by Country
6.1 Europe Hyaluronic Acid for Osteoarthritis Historic Market Size by Country
6.1.1 Europe Hyaluronic Acid for Osteoarthritis Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Hyaluronic Acid for Osteoarthritis Sales in Volume by Country (2018-2023)
6.1.3 Europe Hyaluronic Acid for Osteoarthritis Sales in Value by Country (2018-2023)
6.2 Europe Hyaluronic Acid for Osteoarthritis Forecasted Market Size by Country
6.2.1 Europe Hyaluronic Acid for Osteoarthritis Sales in Volume by Country (2024-2029)
6.2.2 Europe Hyaluronic Acid for Osteoarthritis Sales in Value by Country (2024-2029)
7 Asia-Pacific Hyaluronic Acid for Osteoarthritis by Region
7.1 Asia-Pacific Hyaluronic Acid for Osteoarthritis Historic Market Size by Region
7.1.1 Asia-Pacific Hyaluronic Acid for Osteoarthritis Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Hyaluronic Acid for Osteoarthritis Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Hyaluronic Acid for Osteoarthritis Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Hyaluronic Acid for Osteoarthritis Forecasted Market Size by Region
7.2.1 Asia-Pacific Hyaluronic Acid for Osteoarthritis Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Hyaluronic Acid for Osteoarthritis Sales in Value by Region (2024-2029)
8 Latin America Hyaluronic Acid for Osteoarthritis by Country
8.1 Latin America Hyaluronic Acid for Osteoarthritis Historic Market Size by Country
8.1.1 Latin America Hyaluronic Acid for Osteoarthritis Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Hyaluronic Acid for Osteoarthritis Sales in Volume by Country (2018-2023)
8.1.3 Latin America Hyaluronic Acid for Osteoarthritis Sales in Value by Country (2018-2023)
8.2 Latin America Hyaluronic Acid for Osteoarthritis Forecasted Market Size by Country
8.2.1 Latin America Hyaluronic Acid for Osteoarthritis Sales in Volume by Country (2024-2029)
8.2.2 Latin America Hyaluronic Acid for Osteoarthritis Sales in Value by Country (2024-2029)
9 Middle East and Africa Hyaluronic Acid for Osteoarthritis by Country
9.1 Middle East and Africa Hyaluronic Acid for Osteoarthritis Historic Market Size by Country
9.1.1 Middle East and Africa Hyaluronic Acid for Osteoarthritis Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Hyaluronic Acid for Osteoarthritis Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Hyaluronic Acid for Osteoarthritis Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Hyaluronic Acid for Osteoarthritis Forecasted Market Size by Country
9.2.1 Middle East and Africa Hyaluronic Acid for Osteoarthritis Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Hyaluronic Acid for Osteoarthritis Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 BIOVENTUS
10.1.1 BIOVENTUS Company Information
10.1.2 BIOVENTUS Introduction and Business Overview
10.1.3 BIOVENTUS Hyaluronic Acid for Osteoarthritis Sales, Revenue and Gross Margin (2018-2023)
10.1.4 BIOVENTUS Hyaluronic Acid for Osteoarthritis Products Offered
10.1.5 BIOVENTUS Recent Development
10.2 Sanofi
10.2.1 Sanofi Company Information
10.2.2 Sanofi Introduction and Business Overview
10.2.3 Sanofi Hyaluronic Acid for Osteoarthritis Sales, Revenue and Gross Margin (2018-2023)
10.2.4 Sanofi Hyaluronic Acid for Osteoarthritis Products Offered
10.2.5 Sanofi Recent Development
10.3 Ferring B.V.
10.3.1 Ferring B.V. Company Information
10.3.2 Ferring B.V. Introduction and Business Overview
10.3.3 Ferring B.V. Hyaluronic Acid for Osteoarthritis Sales, Revenue and Gross Margin (2018-2023)
10.3.4 Ferring B.V. Hyaluronic Acid for Osteoarthritis Products Offered
10.3.5 Ferring B.V. Recent Development
10.4 Anika Therapeutics
10.4.1 Anika Therapeutics Company Information
10.4.2 Anika Therapeutics Introduction and Business Overview
10.4.3 Anika Therapeutics Hyaluronic Acid for Osteoarthritis Sales, Revenue and Gross Margin (2018-2023)
10.4.4 Anika Therapeutics Hyaluronic Acid for Osteoarthritis Products Offered
10.4.5 Anika Therapeutics Recent Development
10.5 Fidia Farma
10.5.1 Fidia Farma Company Information
10.5.2 Fidia Farma Introduction and Business Overview
10.5.3 Fidia Farma Hyaluronic Acid for Osteoarthritis Sales, Revenue and Gross Margin (2018-2023)
10.5.4 Fidia Farma Hyaluronic Acid for Osteoarthritis Products Offered
10.5.5 Fidia Farma Recent Development
10.6 LG Chem
10.6.1 LG Chem Company Information
10.6.2 LG Chem Introduction and Business Overview
10.6.3 LG Chem Hyaluronic Acid for Osteoarthritis Sales, Revenue and Gross Margin (2018-2023)
10.6.4 LG Chem Hyaluronic Acid for Osteoarthritis Products Offered
10.6.5 LG Chem Recent Development
10.7 Bohus BioTech
10.7.1 Bohus BioTech Company Information
10.7.2 Bohus BioTech Introduction and Business Overview
10.7.3 Bohus BioTech Hyaluronic Acid for Osteoarthritis Sales, Revenue and Gross Margin (2018-2023)
10.7.4 Bohus BioTech Hyaluronic Acid for Osteoarthritis Products Offered
10.7.5 Bohus BioTech Recent Development
10.8 Hangzhou Singclean Medical Products
10.8.1 Hangzhou Singclean Medical Products Company Information
10.8.2 Hangzhou Singclean Medical Products Introduction and Business Overview
10.8.3 Hangzhou Singclean Medical Products Hyaluronic Acid for Osteoarthritis Sales, Revenue and Gross Margin (2018-2023)
10.8.4 Hangzhou Singclean Medical Products Hyaluronic Acid for Osteoarthritis Products Offered
10.8.5 Hangzhou Singclean Medical Products Recent Development
10.9 Biolevox
10.9.1 Biolevox Company Information
10.9.2 Biolevox Introduction and Business Overview
10.9.3 Biolevox Hyaluronic Acid for Osteoarthritis Sales, Revenue and Gross Margin (2018-2023)
10.9.4 Biolevox Hyaluronic Acid for Osteoarthritis Products Offered
10.9.5 Biolevox Recent Development
10.10 Vivacy
10.10.1 Vivacy Company Information
10.10.2 Vivacy Introduction and Business Overview
10.10.3 Vivacy Hyaluronic Acid for Osteoarthritis Sales, Revenue and Gross Margin (2018-2023)
10.10.4 Vivacy Hyaluronic Acid for Osteoarthritis Products Offered
10.10.5 Vivacy Recent Development
10.11 ideolab
10.11.1 ideolab Company Information
10.11.2 ideolab Introduction and Business Overview
10.11.3 ideolab Hyaluronic Acid for Osteoarthritis Sales, Revenue and Gross Margin (2018-2023)
10.11.4 ideolab Hyaluronic Acid for Osteoarthritis Products Offered
10.11.5 ideolab Recent Development
10.12 Xediton Pharmaceuticals
10.12.1 Xediton Pharmaceuticals Company Information
10.12.2 Xediton Pharmaceuticals Introduction and Business Overview
10.12.3 Xediton Pharmaceuticals Hyaluronic Acid for Osteoarthritis Sales, Revenue and Gross Margin (2018-2023)
10.12.4 Xediton Pharmaceuticals Hyaluronic Acid for Osteoarthritis Products Offered
10.12.5 Xediton Pharmaceuticals Recent Development
10.13 Deka
10.13.1 Deka Company Information
10.13.2 Deka Introduction and Business Overview
10.13.3 Deka Hyaluronic Acid for Osteoarthritis Sales, Revenue and Gross Margin (2018-2023)
10.13.4 Deka Hyaluronic Acid for Osteoarthritis Products Offered
10.13.5 Deka Recent Development
10.14 BIOIBERICA
10.14.1 BIOIBERICA Company Information
10.14.2 BIOIBERICA Introduction and Business Overview
10.14.3 BIOIBERICA Hyaluronic Acid for Osteoarthritis Sales, Revenue and Gross Margin (2018-2023)
10.14.4 BIOIBERICA Hyaluronic Acid for Osteoarthritis Products Offered
10.14.5 BIOIBERICA Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Hyaluronic Acid for Osteoarthritis Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Hyaluronic Acid for Osteoarthritis Industrial Chain Analysis
11.4 Hyaluronic Acid for Osteoarthritis Market Dynamics
11.4.1 Hyaluronic Acid for Osteoarthritis Industry Trends
11.4.2 Hyaluronic Acid for Osteoarthritis Market Drivers
11.4.3 Hyaluronic Acid for Osteoarthritis Market Challenges
11.4.4 Hyaluronic Acid for Osteoarthritis Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Hyaluronic Acid for Osteoarthritis Distributors
12.3 Hyaluronic Acid for Osteoarthritis Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

Published By : QY Research

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock